EQT (EQT) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jan, 2026Executive summary
Achieved high-end Q4 2024 production guidance of 605 Bcfe despite 27 Bcfe in curtailments, driven by operational efficiency and strong well performance.
Equitrans acquisition closed in July 2024, with 90% integration within six months and ~85% of base synergies realized, accelerating cost reductions.
Generated $588 million in free cash flow in Q4, with asset sales and JV proceeds of ~$4.7 billion reducing net debt to ~$9.1 billion by year-end.
Proved reserves remained stable at 26–26.3 Tcfe year-over-year, despite lower SEC price decks and asset sales.
2025 production guidance set at 2,175–2,275 Bcfe, 125 Bcfe above prior outlook, reflecting well performance and compression investments.
Financial highlights
Q4 sales volumes reached 605 Bcfe, at the high end of guidance; normalized for curtailments, production would have been 632 Bcfe.
Q4 net cash from operating activities was $756 million; free cash flow was $588 million; adjusted EBITDA was $1.41 billion.
Q4 operating costs were $1.07 per Mcfe, at the low end of guidance; CapEx was $583 million, 7% below guidance.
Asset sales and JV proceeds totaled ~$4.7 billion, reducing net debt from $13.7 billion to $9.1 billion by year-end.
Q4 average realized price was $3.01 per Mcfe, up from $2.75 in Q4 2023.
Outlook and guidance
2025 production guidance is 2,175–2,275 Bcfe, with a midpoint 125 Bcfe above prior outlook, driven by well performance and efficiency gains.
Maintenance capital budget for 2025 is $1.95–2.12 billion, with $350–380 million for growth projects.
Reserve development capital budget is $1.35–1.45 billion, down nearly 10% per unit from 2024.
Free cash flow expected at ~$2.6 billion in 2025 and ~$3.3 billion in 2026 at recent strip pricing.
Net debt expected to fall to ~$7 billion by end of 2025, with a medium-term target of $5 billion.
Latest events from EQT
- Virtual meeting to elect directors, approve compensation, and ratify auditor on April 14, 2026.EQT
Proxy Filing26 Feb 2026 - 2026 proxy details strong results, ESG leadership, and key votes on directors, pay, and incentives.EQT
Proxy Filing26 Feb 2026 - Record 2025 results and efficiency gains drive strong 2026 outlook and further deleveraging.EQT
Q4 202518 Feb 2026 - Shareholders approved key merger-related proposals, paving the way for the Equitrans deal.EQT
EGM 20243 Feb 2026 - Early Equitrans acquisition, higher sales, and lower net debt drive improved 2024 outlook.EQT
Q2 20243 Feb 2026 - Q3 featured Equitrans integration, $1.25B asset sale, and 60% of 2025 output hedged at $3.25.EQT
Q3 202417 Jan 2026 - Record Q1, Olympus acquisition, and raised guidance underscore strong financial momentum.EQT
Q1 202520 Dec 2025 - Equitrans acquisition, net zero emissions, and robust financials drive key 2025 proxy votes.EQT
Proxy Filing1 Dec 2025 - Completed a major acquisition, achieved net zero emissions, and posted strong financial results.EQT
Proxy Filing1 Dec 2025